Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Alexandre

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Emerging Microbes & Infections|November 19, 2024
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trialSimon Valayer, Marie Alexandre, Mélanie Prague, et al.
Breast (Edinburgh, Scotland)|May 20, 2026
Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohortMarie Alexandre, Eva Teruel, Florence Dalenc, et al.
Breast Cancer Research and Treatment|October 23, 2021
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancerPauline Corbaux, Audrey Lardy-Cleaud, Marie Alexandre, et al.
Plos Neglected Tropical Diseases|January 30, 2026
Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trialAnge-Marie D Kpetigo, Marie Alexandre, Aboubacar Camara, et al.
Ebiomedicine|July 1, 2026
Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primatesRomain Marlin, Mireille Centlivre, Laetitia Bossevot, et al.
Plos One|January 14, 2025
Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Plos One|March 30, 2023
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Emerging Microbes & Infections|November 19, 2024
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trialSimon Valayer, Marie Alexandre, Mélanie Prague, et al.
Breast (Edinburgh, Scotland)|May 20, 2026
Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohortMarie Alexandre, Eva Teruel, Florence Dalenc, et al.
Breast Cancer Research and Treatment|October 23, 2021
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancerPauline Corbaux, Audrey Lardy-Cleaud, Marie Alexandre, et al.
Plos Neglected Tropical Diseases|January 30, 2026
Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trialAnge-Marie D Kpetigo, Marie Alexandre, Aboubacar Camara, et al.
Ebiomedicine|July 1, 2026
Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primatesRomain Marlin, Mireille Centlivre, Laetitia Bossevot, et al.
Plos One|January 14, 2025
Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Plos One|March 30, 2023
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocolSuzanne Penfold, Ayola Akim Adegnika, Danny Asogun, et al.
Pageof 4